CHLAMYDIA - ANVISA Registration 10338930091

Access comprehensive regulatory information for CHLAMYDIA in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10338930091 and manufactured by manufacturer not specified. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until Mar 31, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG, VIRCELL S.L., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10338930091
2 Related Devices
Registration Details
ANVISA Registration Number: 10338930091
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

ANTI-CLAMIDIA MIF IGG
Risk Class IV

Registration Details

10338930091

25351043521201431

93741726000166

Company Information

Dates and Status

Mar 31, 2014

31/03/2034

09/18/2025 19:00:01

ANTI-CLAMIDIA MIF IGG
Risk Class IV

Registration Details

10338930091

25351043521201431

93741726000166

Company Information

Germany
PT: ALEMANHA

Dates and Status

Mar 31, 2014

31/03/2034

09/18/2025 19:00:01